Sponsor Pipeline

MBrace Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
4
Disease Areas
Active Trials by Phase
Phase 1/2
2
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07145255 Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors Prostate Cancer Castration-resistant Prostate Cancer Recruiting
NCT06014658 Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors Cancer Recruiting
Disease Areas
Lung Cancer (1) Breast Cancer (1) Prostate Cancer (1) Colorectal Cancer (1)
Get alerts when MBrace Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free